These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 15389273)

  • 41. Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation.
    Theodossiadis PG; Markomichelakis NN; Sfikakis PP
    Retina; 2007; 27(4):399-413. PubMed ID: 17420690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term efficacy and safety of infliximab in the treatment of Behçet's disease.
    Capella MJ; Foster CS
    Ocul Immunol Inflamm; 2012 Jun; 20(3):198-202. PubMed ID: 22486265
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis.
    Saurenmann RK; Levin AV; Rose JB; Parker S; Rabinovitch T; Tyrrell PN; Feldman BM; Laxer RM; Schneider R; Silverman ED
    Rheumatology (Oxford); 2006 Aug; 45(8):982-9. PubMed ID: 16461435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitis.
    Murphy CC; Greiner K; Plskova J; Frost NA; Forrester JV; Dick AD
    Br J Ophthalmol; 2007 Feb; 91(2):154-6. PubMed ID: 16973657
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Favorable response to high-dose infliximab for refractory childhood uveitis.
    Kahn P; Weiss M; Imundo LF; Levy DM
    Ophthalmology; 2006 May; 113(5):860-4.e2. PubMed ID: 16545455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema.
    Taylor SR; Habot-Wilner Z; Pacheco P; Lightman SL
    Ophthalmology; 2009 Apr; 116(4):797-801. PubMed ID: 19344827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis.
    Jaffe GJ
    Am J Ophthalmol; 2008 Apr; 145(4):667-675. PubMed ID: 18226800
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-TNF-α therapy in refractory uveitis associated with sarcoidosis: Multicenter study of 17 patients.
    Riancho-Zarrabeitia L; Calvo-Río V; Blanco R; Mesquida M; Adan AM; Herreras JM; Aparicio Á; Peiteado-Lopez D; Cordero-Coma M; García Serrano JL; Ortego-Centeno N; Maíz O; Blanco A; Sánchez-Bursón J; González-Suárez S; Fonollosa A; Santos-Gómez M; González-Vela C; Loricera J; Pina T; González-Gay MA
    Semin Arthritis Rheum; 2015 Dec; 45(3):361-8. PubMed ID: 26092330
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interleukin-1β-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcet's disease: an open-label pilot study.
    Gül A; Tugal-Tutkun I; Dinarello CA; Reznikov L; Esen BA; Mirza A; Scannon P; Solinger A
    Ann Rheum Dis; 2012 Apr; 71(4):563-6. PubMed ID: 22084392
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Posterior subtenon and intravitreal triamcinolone acetonide for diabetic macular edema.
    Ozdek S; Bahçeci UA; Gürelik G; Hasanreisoğlu B
    J Diabetes Complications; 2006; 20(4):246-51. PubMed ID: 16798476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cyclosporin A in the treatment of posterior uveitis.
    Graham EM; Sanders MD; James DG; Hamblin A; Kasp Grochowska E; Dumonde D
    Trans Ophthalmol Soc U K (1962); 1985; 104 ( Pt 2)():146-51. PubMed ID: 3857775
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term infliximab treatment in rheumatoid arthritis: subsequent outcome of initial responders.
    Buch MH; Bingham SJ; Bryer D; Emery P
    Rheumatology (Oxford); 2007 Jul; 46(7):1153-6. PubMed ID: 17478470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-TNF-alpha therapy for uveitis: Behçet and beyond.
    Murray PI; Sivaraj RR
    Eye (Lond); 2005 Aug; 19(8):831-3. PubMed ID: 16086039
    [No Abstract]   [Full Text] [Related]  

  • 54. Health- and vision-related quality of life in patients receiving infliximab therapy for Behcet uveitis.
    Sakai T; Watanabe H; Kuroyanagi K; Akiyama G; Okano K; Kohno H; Tsuneoka H
    Br J Ophthalmol; 2013 Mar; 97(3):338-42. PubMed ID: 23314623
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intraoperative use of intravitreal triamcinolone in uveitic eyes having cataract surgery: pilot study.
    Okhravi N; Morris A; Kok HS; Menezo V; Dowler JG; Hykin PG; Lightman S
    J Cataract Refract Surg; 2007 Jul; 33(7):1278-83. PubMed ID: 17586387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up.
    Molloy ES; Langford CA; Clark TM; Gota CE; Hoffman GS
    Ann Rheum Dis; 2008 Nov; 67(11):1567-9. PubMed ID: 18677012
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Focus on adverse events of tumour necrosis factor alpha blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients.
    Gerloni V; Pontikaki I; Gattinara M; Fantini F
    Ann Rheum Dis; 2008 Aug; 67(8):1145-52. PubMed ID: 17981916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.
    Aringer M; Graninger WB; Steiner G; Smolen JS
    Arthritis Rheum; 2004 Oct; 50(10):3161-9. PubMed ID: 15476222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infliximab efficacy and safety against refractory systemic necrotising vasculitides: long-term follow-up of 15 patients.
    Josselin L; Mahr A; Cohen P; Pagnoux C; Guaydier-Souquières G; Hayem G; Job-Deslandre C; Liferman F; Pourrat J; Guillevin L
    Ann Rheum Dis; 2008 Sep; 67(9):1343-6. PubMed ID: 18445626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.
    Iwata S; Saito K; Yamaoka K; Tsujimura S; Nawata M; Suzuki K; Tanaka Y
    Rheumatology (Oxford); 2009 Aug; 48(8):1012-3. PubMed ID: 19465589
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.